Cytokinetics stock forecast
WebMar 7, 2024 · Future criteria checks 0/6. Cytokinetics, Incorporated's earnings is forecasted to decline at 23.5% and its revenue is expected to decline at 46.6%. Cytokinetics, Incorporated has a predicted EPS and ROE of 27.5% and -44.7% respectively. WebFeb 13, 2024 · Cytokinetics Stock Forecast and Price Target In recent months, two notable analysts have provided yearlong price targets for Cytokinetics, with the average …
Cytokinetics stock forecast
Did you know?
WebStock analysis for Cytokinetics Inc (CYTK:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. WebFeb 28, 2024 · Cytokinetics Stock Up 0.4 %. Shares of CYTK opened at $42.98 on Tuesday. Cytokinetics, Incorporated has a 52 week low of $33.10 and a 52 week high of $55.80. The firm has a market cap of $4.07 billion, a P/E ratio of -13.60 and a beta of 0.90. The firm's 50-day simple moving average is $43.66 and its 200 day simple moving …
Web1 day ago · See the latest Cytokinetics Inc stock price (NASDAQ:CYTK), related news, valuation, dividends and more to help you make your investing decisions. WebApr 10, 2024 · Cytokinetics NasdaqGS:CYTK Stock Report. Last Price. US$34.99. Market Cap. US$3.3b. 7D-7.2%. 1Y-14.8%. Updated. 10 Apr, 2024. Data. Company Financials + 14 Analysts. ... Broker Revenue Forecasts For Cytokinetics, Incorporated (NASDAQ:CYTK) Are Surging Higher Jan 09. Cytokinetics: Biotech That Should Be On Your Radar With …
WebOn average, Wall Street analysts predict that Cytokinetics 's share price could reach $58.27 by Mar 31, 2024. The average Cytokinetics stock price prediction forecasts a … WebApr 10, 2024 · Virtual Stock Exchange; Video. MarketWatch 25 Years; SectorWatch; ... Spinal Muscular Atrophy Medicine Market Size And Forecast. ... Roche acquired Cytokinetics, Inc.'s SMA program, which is a ...
WebApr 2, 2024 · In 2024, Cytokinetics reported revenues of $2.0 million for Q4 and $94.6 million for the full year, compared to $55.6 million and $70.4 million in the same periods …
WebApr 10, 2024 · 2. Markets Today: Stock Indexes Fall on Weakness in Tech Stocks. 3. Option Volatility And Earnings Report For April 10 - 14. 4. Despite a Potential Devon Energy Dividend Cut, Investors Short Its Puts for Income. 5. Stocks Set to Open Lower as Investors Await FOMC Minutes, Inflation Data. imm living totem bowlsWebAug 8, 2024 · But note: Cytokinetics may not be the best stock to buy. So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast). list of topic for speechWebCytokinetics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Cytokinetics, Inc. 's performance made by these … imml bathWebFind the latest Cytokinetics, Incorporated CYTK analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range … immke honda used carsWebApr 2, 2024 · Posted by MarketBeat News on Apr 2nd, 2024. Shares of Cytokinetics, Incorporated ( NASDAQ:CYTK – Get Rating) gapped up before the market opened on Friday . The stock had previously closed at $34 ... immluth.orgWebApr 13, 2024 · The projected fair value for Cytokinetics is US$38.04 based on 2 Stage Free Cash Flow to Equity. Cytokinetics' US$34.05 share price indicates it is trading at similar levels as its fair value estimate immlaw group apsWebMar 20, 2024 · The latest price target for . Cytokinetics (NASDAQ: CYTK) was reported by JP Morgan on March 20, 2024.The analyst firm set a price target for $52.00 expecting CYTK to rise to within 12 months (a ... im ml amount